C12N 2770/36061
Methods of inactivation or attenuation
C12N2770/36061 (Methods of inactivation or attenuation) appears on 4 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 11
- Assignees
- 4
- Inventors
- 15
- Latest grant
- 19 Dec 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 3 |
| 2025 | 0 | 1 |
By publication year.
Subgroups
Granted patents
Recent patents
- Compositions and methods for enhancing gene expression19 Dec 2023US 11,845,939 B2Janssen Pharmaceuticals, Inc.
- Methods for viral inactivation and other adventitious agents22 Jan 2019US 10,184,106 B2Genentech, Inc.
- Methods for viral inactivation and other adventitious agents15 Nov 2016US 9,493,744 B2Genentech, Inc.
- Live attenuated viral vaccines for Eastern Equine Encephalitis virus7 Sep 2010US 7,790,181 B2The United States of America as represented by the Secretary of the Army
- Methods for viral inactivation and other adventitious agents3 Apr 2025US 2025/0109376 A1Genentech, Inc.
- Continuous flow, high throughput apparatus and method for inactivating viruses and pathogens in human plasma24 Oct 2024US 2024/0350691 A1Aphios Corporation
- Methods for viral inactivation and other adventitious agents19 Sep 2024US 2024/0309314 A1Genentech, Inc.
- Compositions and methods for enhancing gene expression27 Jun 2024US 2024/0209379 A1Janssen Pharmaceuticals, Inc.
- Methods for viral inactivation and other adventitious agents25 May 2023US 2023/0159886 A1Genentech, Inc.
Most cited
By later US patents